483
Grifols Therapeutics LLCGrifols Therapeutics LLC – FDA 483, Apr 1, 2014
Record Details
Grifols Therapeutics Inc. in Clayton, NC, was inspected regarding its plasma fractionation operations. The inspection revealed significant issues including product stability concerns with Albumin, incomplete sterility investigations for Prolastin, inadequate media fill accountability, and poor aseptic practices during filling. Additionally, several facility and equipment maintenance deficiencies were noted, indicating a moderate level of severity.
View Company Profile
ID · fe4782b9-258b-4f75-953d-f2ca64b7f6eb
Other documents for Grifols Therapeutics LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.